Douglas E. Brough
Corporate Officer/Principal presso PRECIGEN, INC.
Posizioni attive di Douglas E. Brough
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Douglas E. Brough
Precedenti posizioni note di Douglas E. Brough
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENVEC INC | Direttore Tecnico/Scientifico/R&S | 01/09/2013 | 16/06/2017 |
Formazione di Douglas E. Brough
| Purdue University | Undergraduate Degree |
| Idaho State University | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Borsa valori
- Insiders
- Douglas E. Brough
- Esperienza
